The Company is maintaining its previously issued 2024 revenue guidance of $79-81M and confirms its view of expected adjusted EBITDA profitability in the first half of 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MDXH:
- Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
- Is MDXH a Buy, Before Earnings?
- MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6
- MDxHealth director Jan Pensaert resigns
- MDxHealth Sees FY23 revenue $70.2M, consensus $69.15M